Poseida Therapeutics, Inc.

Poseida Therapeutics, Inc.

Biotechnology Research 9390 Towne Centre Dr 218 employees
Employees
218
Contacts
3
Emails
3
Phones
1

Poseida Therapeutics, Inc. Overview

Headquarters
9390 Towne Centre Dr
Phone Number
Available in AeroLeads
Website
poseida.com
Industry
Biotechnology Research
Employees
218
Founded
2014
Funding
50.0M
Company Email
Available in AeroLeads
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

About Poseida Therapeutics, Inc.

Poseida was acquired by Roche in early 2025 and is now part of the Roche Group. Poseida is a clinical-stage biopharmaceutical company advancing differentiated allogeneic cell therapies and genetic medicines with the capacity to cure. The Company's approach is based on its proprietary genetic editing platforms, including its non-viral DNA Delivery System, Cas-CLOVER™ Site-Specific Gene Editing System, Booster Molecule and nanoparticle gene delivery technologies, as well as in-house GMP cell therapy manufacturing.

Poseida Therapeutics, Inc. Contact Details

People in AeroLeads
4
With contact data
3
Email contacts
3
75.0% coverage
Phone contacts
1
25.0% coverage

Poseida Therapeutics, Inc. Org Chart

Sample employees and titles
Name Title Contact
Eric Ostertag Retired
View
Ian Popoff Vice President, Program Leadership, Project Management, Portfolio Management, Strategic Planning, Pmo
Email
Vishal Goyal Director @ Poseida Therapeutics, Inc. - Information Technology, Hands on, Leadership, Strategy, Start-up
Email Phone
Melissa Simonsen
Email

Employees by Management Level

Individual contributor 12 profiles
Manager 8 profiles
Director 5 profiles
Senior / Lead 5 profiles
Executive 3 profiles
Associate / junior 1 profile

Department Contact Coverage

Department Contacts Email Phone
General 8 8 2
IT 4 4 0
Operations 3 3 0
Executive 2 2 1
Healthcare 1 1 0
Finance 1 1 0

Poseida Therapeutics, Inc. Tech Stack

Data / AI 4 profiles
Engineering 3 profiles
Cloud / infrastructure 1 profile

Compare Similar Companies to Poseida Therapeutics, Inc.